Abdel-Kader K .2022 .Symptoms with or because of kidney failure?. Clin. J. Am. Soc. Nephrol., 17(4) : 475-477.
Abe K,Fujita M,Hayashi M,Takahashi A,Ohira H A .2021 .The efficacy of levocarnitine treatment in relieving fatigue in patients with cirrhosis but without overt hepatic encephalopathy. Intern. Med, 60(22) : 3533-3542.
Arastu AH,Elstrott BK,Martens KL,Cohen JL,Oakes MH,Rub ZT,Aslan JJ,DeLoughery TG,Shatzel J .2022 .Analysis of adverse events and intravenous iron infusion formulations in adults with and without prior infusion reactions. JAMA Netw, 5(3) : e224488.
Avdonin PP,Blinova MS,Generalova GA,Emirova KM,Avdonin PV .2023 .The role of the complement system in the pathogenesis of infectious forms of hemolytic uremic syndrome. , 14(1) : 39.
Boyer O and Niaudet P .2022 .Hemolytic-Uremic Syndrome in Children. , 69(6) : 1181-1197.
Calo LA,Vertolli U,Davis PA,Savica V .2012 .L carnitine in hemodialysis patients. Hemodial. Int., 16(3) : 428-434.
Dave CV,Brittenham GM,Carson JL,Setoguchi S JL .2022 .Risks for anaphylaxis with intravenous iron formulations: A retrospective cohort study. Ann. Intern. Med, 175(5) : 656-664.
He H and Xie Y .2021 .Alteration of intestinal microflora in uremia patients with or without blood purification. Niger. J. Clin. Pract, 24(8) : 1133-1137.
Kashani K,Cozzolino MG,Massy ZA,Blankestijn PJ,Stenvinkel P,Rosner MH,Ronco C .2023 .Proposal for a new classification of solutes of interest in uremia and hemodialysis. Blood Purif, 52(3) : 233-241.
Koekkoek KWA,Berger MM .2023 .An update on essential micronutrients in critical illness. Curr. Opin. Crit. Care., 29(4) : 315-329.
Macdougall IC,Comin-Colet J,Breymann C,Spahn DR,Koutroubakis IE .2020 .Iron sucrose: A wealth of experience in treating iron deficiency. Adv. Ther., 37(5) : 1960-2002.
Meijers B,Zadora W,Lowenstein J .2024 .A historical perspective on uremia and uremic toxins. Toxins, 16(5) : .
Michael M,Bagga A,Sartain SE,Smith RJH SE .2022 .Haemolytic uraemic syndrome. Lancet., 400(10364) : 1722-1740.
Pagano G,Pallardo FV,Porto B,Fittipaldi MR,Lyakhovich A,Trifuoggi M .2020 .Mitoprotective clinical strategies in type 2 diabetes and fanconi anemia patients: Suggestions for clinical management of mitochondrial dysfunction. Antioxidants, 9(1) : .
Rehman S,Farhan M,Kumar S,Sarfraz MR,Naveed A,Khan MT,Huq H MT .2025 .Efficacy of intravenous versus oral administration of levocarnitine in maintenance hemodialysis patients: A randomized controlled trial investigating therapeutic approaches to renal anemia. Health Sci. Rep, 8(1) : e70297.
Sindone A,Doehner W,Comin-Colet J .2023 .Systematic review and meta-analysis of intravenous iron-carbohydrate complexes in HFrEF patients with iron deficiency. ESC Heart Fail., 10(1) : 44-56.
Song MJ,Park CH,Kim H,Han S,Lee SH,Lee DH,Chung JH .2023 .Carnitine acetyltransferase deficiency mediates mitochondrial dysfunction-induced cellular senescence in dermal fibroblasts. Aging Cell., 22(11) : e14000.
Wang P,Guo C,Pan H,Chen W,Peng D .2021 .Iron sucrose: A double-edged sword in high phosphate media-induced vascular calcification. Calcif. Tissue Int, 108(6) : 798-807.
Yan J,Winkelmayer WC,Walther CP .2023 .Iron sucrose and blood pressure patterns during hemodialysis. Am. J. Kidney Dis, 81(6) : 629-631.